期刊文献+

LRG-1在溃疡性结肠炎与结直肠癌组织中的表达 被引量:1

Expression of LRG-1 in ulcerative colitis and colorectal cancer tissues
下载PDF
导出
摘要 目的观察富亮氨酸α2糖蛋白1(LRG-1)在溃疡性结肠炎(UC)及结直肠癌(CRC)组织中的表达。方法选取40只C57BL/6J雄性小鼠,随机分为对照组,急性、慢性UC组及UC癌变组,每组各10只。除对照组外,采用偶氮氧甲烷(AOM)及葡聚糖硫酸钠法(DSS)建立急、慢性UC及UC癌变模型,采用实时荧光定量PCR(qRTPCR)检测各组LRG-1 mRNA表达。另收集行结肠镜检并取病理活检的正常结肠黏膜组织20例份,UC组织30例份,CRC组织30例份,通过免疫组化法和qRT-PCR法检测各组织中LRG-1 mRNA及蛋白表达。结果与对照组小鼠比较,LRG-1 mRNA表达在急性、慢性UC组、UC癌变组逐渐增高,组间比较有统计学差异(P均<0.05)。人正常结肠黏膜组织、UC及CRC组织中LRG-1 mRNA及蛋白表达逐渐增高,组间比较有统计学差异(P均<0.05)。结论 LRG-1在UC和CRC组织中呈高表达,其可能在UC、CRC发生发展中发挥重要作用。 Objective To investigate the expression and significance of leucine-rich α2 glycoprotein-1( LRG-1) in the ulcerative colitis( UC) and colorectal cancer( CRC) tissues. Methods We randomly divided forty male C57 BL/6 J mice into four groups with 10 in each group: the control group,acute UC group,chronic UC group,and UC-associated cancer group. We induced the acute and chronic UC with dextran sodium sulfate( DSS),and carcinogenesis by addition of azoxymethane( AOM). We measured the mRNA expression level of LRG-1 by real-time polymerase chain reaction( qRTPCR) in the colorectal mucosal tissues of mice from four groups. We assessed the mRNA and protein levels of LRG1 by qRT-PCR and immunohistochemistry in the colorectal mucosal tissues obtained from 20 healthy individuals,30 active UC patients,and 30 CRC patients. Results Compared with the control group,the expression level of LRG-1 mRNA in the active UC,chronic UC,and UC-associated cancer group increased progressively. The difference was statistically significant among these four groups( all P〈0. 05). Compared with the healthy individuals,the mRNA and protein expression levels of LRG-1 in the active UC and CRC patients increased gradually. The difference was statistically significant among these three groups( all P〈0. 05). Conclusion LRG-1 is highly expressed in UC and CRC tissues,and its high expression plays an important role in the occurrence and development of UC and CRC.
作者 刘肇修 管程齐 陆翠华 肖明兵 倪润洲 卞兆连 LIU Zhaoxiu;GUAN Chengqi;LU Cuihua;XIAO Mingbing;NI Runzhou;BIAN Zhaolian(The Affiliated Hospital of Nantong University,Nantong 226001,China)
出处 《山东医药》 CAS 2018年第25期9-12,共4页 Shandong Medical Journal
基金 江苏省卫计委资助项目(H201624) 江苏省"青年医学重点人才"资助项目(QNRC2016697)
关键词 溃疡性结肠炎 结肠癌 肠炎相关性肠癌 富亮氨酸α2糖蛋白1 ulcerative colitis colorectal carcinoma ulcerative colitis-associated cancer leucine-rich α2-glycopro-tein-1
  • 相关文献

参考文献2

二级参考文献120

  • 1高翔,胡品津,何瑶,廖山婴,彭穗,陈旻湖.炎症性肠病患者血清中自身抗体检测的临床意义[J].中华内科杂志,2005,44(6):428-430. 被引量:39
  • 2刘思德,姜泊,周殿元.放大内镜结合黏膜染色技术诊断溃疡性结肠炎——附116例放大内镜形态分析[J].现代消化及介入诊疗,2005,10(2):116-118. 被引量:8
  • 3李亚红,韩英,吴开春.炎症性肠病危险因素的流行病学调查研究[J].胃肠病学和肝病学杂志,2006,15(2):161-162. 被引量:19
  • 4Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Currentmanagement of inflammatory bowel disease and colorectal cancer.Gastrointest Cancer Res 2011; 4: 53-61 [PMID: 21673876].
  • 5Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease.World J Gastroenterol 2008; 14: 378-389 [PMID: 18200660 DOI:10.3748/wjg.14.378].
  • 6Kaplan GG. The global burden of IBD: from 2015 to 2025. NatRev Gastroenterol Hepatol 2015; 12: 720-727 [PMID: 26323879DOI: 10.1038/nrgastro.2015.150].
  • 7Nielsen OH. New strategies for treatment of inflammatory boweldisease. Front Med (Lausanne) 2014; 1: 3 [PMID: 25685754 DOI:10.3389/fmed.2014.00003].
  • 8Rutgeerts P, Van Assche G, Sandborn WJ, Wolf DC, Geboes K,Colombel JF, Reinisch W, Kumar A, Lazar A, Camez A, LomaxKG, Pollack PF, D'Haens G. Adalimumab induces and maintainsmucosal healing in patients with Crohn's disease: data from theEXTEND trial. Gastroenterology 2012; 142: 1102-1111.e2 [PMID:22326435 DOI: 10.1053/j.gastro.2012.01.035].
  • 9D'haens G, Van Deventer S, Van Hogezand R, Chalmers D,Kothe C, Baert F, Braakman T, Schaible T, Geboes K, RutgeertsP. Endoscopic and histological healing with infliximab antitumornecrosis factor antibodies in Crohn's disease: A Europeanmulticenter trial. Gastroenterology 1999; 116: 1029-1034 [PMID:10220494 DOI: 10.1016/S0016-5085(99)70005-3].
  • 10Niewiadomski O, Studd C, Hair C, Wilson J, Ding NS, HeerasingN, Ting A, McNeill J, Knight R, Santamaria J, Prewett E,Dabkowski P, Dowling D, Alexander S, Allen B, Popp B, ConnellW, Desmond P, Bell S. Prospective population-based cohort ofinflammatory bowel disease in the biologics era: Disease courseand predictors of severity. J Gastroenterol Hepatol 2015; 30:1346-1353 [PMID: 25867770 DOI: 10.1111/jgh.12967].

共引文献680

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部